KURTOĞLU, E. L. Et Al. 2017. Lipoxin A(4) Improves Ultrastructural View of Liver and Reduces Expression Levels of MKK4 and TGF-beta During Thioacetamide (TAA) Induced Fibrosis. HEPATOLOGY , (Washington, Kiribati), 222-223.

KURTOĞLU, E. L., KAYHAN, B., GÜL, M., KAYHAN, B., AKDOĞAN KAYHAN, M., & YILMAZ, S., (2017). Lipoxin A(4) Improves Ultrastructural View of Liver and Reduces Expression Levels of MKK4 and TGF-beta During Thioacetamide (TAA) Induced Fibrosis . HEPATOLOGY (pp.222-223). Washington, Kiribati

KURTOĞLU, ELÇİN Et Al. "Lipoxin A(4) Improves Ultrastructural View of Liver and Reduces Expression Levels of MKK4 and TGF-beta During Thioacetamide (TAA) Induced Fibrosis," HEPATOLOGY, Washington, Kiribati, 2017

KURTOĞLU, ELÇİN L. Et Al. "Lipoxin A(4) Improves Ultrastructural View of Liver and Reduces Expression Levels of MKK4 and TGF-beta During Thioacetamide (TAA) Induced Fibrosis." HEPATOLOGY , Washington, Kiribati, pp.222-223, 2017

KURTOĞLU, E. L. Et Al. (2017) . "Lipoxin A(4) Improves Ultrastructural View of Liver and Reduces Expression Levels of MKK4 and TGF-beta During Thioacetamide (TAA) Induced Fibrosis." HEPATOLOGY , Washington, Kiribati, pp.222-223.

@conferencepaper{conferencepaper, author={ELÇİN LATİFE KURTOĞLU Et Al. }, title={Lipoxin A(4) Improves Ultrastructural View of Liver and Reduces Expression Levels of MKK4 and TGF-beta During Thioacetamide (TAA) Induced Fibrosis}, congress name={HEPATOLOGY}, city={Washington}, country={Kiribati}, year={2017}, pages={222-223} }